MedPath

Aesthetic Performance of an Injective Treatment for the Inner Thighs, Knees and Arms

Not Applicable
Completed
Conditions
Skin Flaccidity Inner Thighs Knees Arms
Interventions
Device: SUNEKOS ® Body
Registration Number
NCT04113265
Lead Sponsor
Derming SRL
Brief Summary

The objective of this study is to investigate the efficacy of the "SUNEKOS® Body" in woman aged 40-65 years with skin flaccidity of the inner thighs, knees and arms.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
24
Inclusion Criteria
  • female sex;
  • age 40-65 years;
  • asking for inner thighs, knees and arms laxity restoration;
  • available and able to return to the study site for the post-procedural follow-up examinations;
  • accepting to not change their habits regarding food, physical activity, cosmetic and cleansing products for the body;
  • accepting not to expose their body to strong UV irradiation (UV session, or sun bathes) during the entire duration of the study, without appropriate sun protection;
  • accepting to sign the informed consent form.
Exclusion Criteria
  • Pregnancy;
  • lactation;
  • smokers;
  • alcohol abuse and/or drug use;
  • subjects not in menopause who do not use adequate contraceptive precautions in order to avoid pregnancies during the study;
  • subjects not in menopause who do not accept to perform the pregnancy test at T0 (before the 1st aesthetic procedure) and at T4i (before the last injection treatment execution);
  • Body Mass Index (BMI) variation (± 1) during the study period;
  • performing skin treatments for knee, thighs and arms aesthetic correction (carboxytherapy injections, body lifting, laser, infrared light, bipolar radiofrequency, vacuum and mechanical massage) in the 6 months prior to the study start;
  • aesthetic surgical procedure on knee, thighs and arms in the past;
  • change in the normal habits regarding food, physical activity, cosmetic products and cleansing for the body during the month preceding the test;
  • sensitivity to the test product or its ingredients (to be assessed by the investigator during the baseline visit);
  • subjects whose insufficient adhesion to the study protocol is foreseeable;
  • participation in a similar study currently or during the previous 6 months
  • Dermatitis;
  • presence of cutaneous disease on the tested area, as lesions, scars, malformations;
  • recurrent facial/labial herpes;
  • clinical and significant skin condition on the test area (e.g. active eczema, psoriasis, severe rosacea, scleroderma, local infections and severe acne).
  • Diabetes;
  • endocrine disease;
  • hepatic disorder;
  • renal disorder;
  • cardiac disorder;
  • pulmonary disease;
  • cancer;
  • neurological or psychological disease;
  • inflammatory/immunosuppressive disease;
  • drug allergy.
  • Anticoagulants and antiplatelet drugs, anti-histaminic, topic and systemic corticosteroids, narcotic, antidepressant, immunosuppressive drugs (with the except of contraceptive or hormonal treatment starting more than 1 year ago);
  • using of drugs able to influence the test results in the investigator opinion.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
SUNEKOS ® BodySUNEKOS ® BodyThe 1st treatment was performed during T0 visit, after the basal evaluations planned by the study procedure and repeated 3 more times with an interval of 1 week (T2i, T3i and T4i).
Primary Outcome Measures
NameTimeMethod
Change from baseline of inner knee skin roughness clinical gradebaseline, 48 hours after the last injection procedure, after 8 weeks, after 16 weeks

Skin laxity clinical grade, according to a visual score from 1 (no roughness) to 5 (very severe roughness)

Change from baseline of superficial skin hydrationbaseline, 48 hours after the last injection procedure, after 8 weeks, after 16 weeks

Skin electrical capacitance value was measured mono-laterally on the right or left inner arm, thigh and knee with Corneometer CM825 (Courage - Khazaka, Köln, Germany). The measure of the skin capacitance properties is an indirect expression of its hydration level.

Change from baseline of photographic documentationbaseline, 48 hours after the last injection procedure, after 8 weeks, after 16 weeks

2D pictures of the inner arm, thigh and knee

Change from baseline of inner arm skin laxity clinical gradebaseline, 48 hours after the last injection procedure, after 8 weeks, after 16 weeks

Skin laxity clinical grade, according to a visual score from 1 (no flaccidity) to 5 (very severe flaccidity)

Change from baseline of inner knee skin laxity clinical gradebaseline, 48 hours after the last injection procedure, after 8 weeks, after 16 weeks

Skin laxity clinical grade, according to a clinical score from 1 (no flaccidity) to 5 (very severe flaccidity)

Change from baseline of inner arm skin roughness clinical gradebaseline, 48 hours after the last injection procedure, after 8 weeks, after 16 weeks

Skin roughness clinical grade, according to a visual score from 1 (no roughness) to 5 (very severe roughness)

Change from baseline of inner thigh skin laxity clinical gradebaseline, 48 hours after the last injection procedure, after 8 weeks, after 16 weeks

Skin laxity clinical grade, according to a visual score from 1 (no flaccidity) to 5 (very severe flaccidity)

Change from baseline of inner thigh skin roughness clinical gradebaseline, 48 hours after the last injection procedure, after 8 weeks, after 16 weeks

Skin laxity clinical grade, according to a clinical score from 1 (no roughness) to 5 (very severe roughness)

Change from baseline of deep skin hydrationbaseline, 48 hours after the last injection procedure, after 8 weeks, after 16 weeks

Tissue dielectric constant value of superficial and deep skin layers was measured mono-laterally on the right or left inner arm, thigh and knee with MoistureMeterD (Delfin Technologies, Kuopio - Finland)

Change from baseline of skin densitybaseline, 48 hours after the last injection procedure, after 8 weeks, after 16 weeks

A little skin area of about 7 cm2 (at level of inner arm was pinched, in standardized conditions, using a specific device. Because of this "pinch" the skin profile changes depending on cutaneous density; when the skin is slack the "pinch" forms a lot of wrinkles. A picture of the skin pinched was taken thanks to Primos compact portable device (GFMesstechnik); Primos software is able to measure skin principal profilometric parameters.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

DERMING

🇮🇹

Milano, MI, Italy

© Copyright 2025. All Rights Reserved by MedPath